Zanolimumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Zanolimumab, covering 2012-12-11 to 2012-12-11. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study of Aldesleukin (IL-2) Following the Administration of Zanolimumab (Anti-CD4mAb) in Metastatic Melanoma and Metastatic Renal Cancer [Phase 2]